e-learning
resources
Vienna 2012
Wednesday, 05.09.2012
The smoking gun in COPD biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD patients with more severe GOLD stages have higher serum cystatin C levels
A. Nowinski, D. Korzybski, D. Kaminski, A. Stoklosa, D. Gorecka (Warsaw, Poland)
Source:
Annual Congress 2012 - The smoking gun in COPD biology
Session:
The smoking gun in COPD biology
Session type:
Poster Discussion
Number:
4583
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Nowinski, D. Korzybski, D. Kaminski, A. Stoklosa, D. Gorecka (Warsaw, Poland). COPD patients with more severe GOLD stages have higher serum cystatin C levels. Eur Respir J 2012; 40: Suppl. 56, 4583
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Serum TGF-β level in patients with different stages of stable COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Elevation of plasma cystatin C levels in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Asthmatics with high levels of serum surfactant protein D have more severe disease
Source: Eur Respir J 2016; 47:1864-1867
Year: 2016
Serum levels of IL-6 in adult patients with moderate to severe asthma.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017
The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
HDL serum levels are significantly lower in patients with COPD than in never-smokers
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Vitamin C level in the serum of smokers and non-smokers with COPD in stable state and during exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 556s
Year: 2007
Plasma vitamin D concentration and clinical characteristics in clinically stable patients with moderate COPD
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D)
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002
Dynamics of marker of inflammation - sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients.
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Content of adiponectin in blood of COPD patients depending on stage of disease and presence of emphysema
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity.
Source: International Congress 2017 – COPD biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept